FIP is no longer a death sentence—thanks to the legal availability of antivirals. Join Antoine Duclos and Dr Samantha Taylor to explore practical guidance on confidently diagnosing FIP and optimising treatment outcomes using antiviral therapies. Don’t miss this essential update for feline vets.
Gain a comprehensive understanding of Feline Infectious Peritonitis (FIP), including its causes, symptoms, diagnosis, available treatments, and how to support cats during and after treatment.
Learn about the growing experience in treating FIP (Feline Infectious Peritonitis) with antiviral drugs in 2024 from leading specialists, offering valuable insights for veterinary professionals.
Feline infectious peritonitis is now a readily treatable disease. In this exciting era of feline medicine, let us learn from past mistakes and do our bit to promote responsible antimicrobial stewardship. Antivirals are often overlooked when we discuss antimicrobial resistance, with most of the focus on antibiotic use. In this webinar, Dr Coggins will review what we have learned from the COVID-19 pandemic and discuss the current recommendations for antiviral use in the context of FIP treatment.
In this session, Dr. Sam Taylor will discuss the latest developments in feline disease management, including how caregivers can support their pets through the treatment process.
Home care and monitoring are an essential part of caring for your cat, when diagnosed with Feline Infectious Peritonitis (FIP). This diary is designed to help you effectively monitor your cat’s condition between veterinary visits, as well as provide valuable insights to your veterinary surgeon.
Join us for an essential webinar tailored for veterinary surgeons grappling with the intricacies of diagnosing and treating Feline Infectious Peritonitis (FIP). Led by esteemed expert Sam Taylor, RCVS Recognised Specialist in Feline Medicine, this webinar will highlight the key clinical abnormalities indicative of FIP, decode lab findings, and address the important question of when treatment trials are appropriate.
The last few years have seen an explosion in our knowledge of treating FIP but where have we landed in terms of drugs, dosage and prognosis?
